Specialty Pharma Journal Specialty, Precision & Technology

WHIPPANY, N.J., May 29, 2019 /PRNewswire/ — Bayer announced today that the U.S. Food and …

SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) …

BOSTON, May 28, 2019 (GLOBE NEWSWIRE) —  Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq:ZIOP), …

INDIANAPOLIS, May 28, 2019 /PRNewswire/ — Eli Lilly and Company(NYSE: LLY) today announced a license agreement to acquire …

NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) — Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical …

Basel, May 24, 2019 – Novartis today announced the US Food and Drug Administration (FDA) has approved …

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess …

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte Corporation (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has …

Basel, May 24, 2019 – AveXis, a Novartis company, today announced the US Food and Drug Administration …

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced that the U.S. Food and Drug Administration …

Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus …

Lille (France), Cambridge (Massachusetts, United States), May 23, 2019 – GENFIT (Nasdaq and Euronext: GNFT), a …

Daix (France), May 23, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small …

Oslo, Norway, 23 May 2019 – Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target …

SAN FRANCISCO, May 23, 2019 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced the formation …